Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts.

Tahara T, Tahara S, Horiguchi N, Okubo M, Terada T, Yamada H, Yoshida D, Omori T, Osaki H, Maeda K, Kamano T, Funasaka K, Nagasaka M, Nakagawa Y, Shibata T, Ohmiya N.

Hum Mutat. 2019 Mar;40(3):347-354. doi: 10.1002/humu.23700. Epub 2019 Jan 15.

PMID:
30575210
2.

Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis.

Tahara T, Hirata I, Nakano N, Tahara S, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Yamada H, Yoshida D, Ohmori T, Maeda K, Komura N, Ikuno H, Jodai Y, Kamano T, Nagasaka M, Nakagawa Y, Tuskamoto T, Urano M, Shibata T, Kuroda M, Ohmiya N.

Oncotarget. 2017 Jun 27;8(37):61917-61926. doi: 10.18632/oncotarget.18716. eCollection 2017 Sep 22.

3.

Methylation status of IGF2 DMR and LINE1 in leukocyte DNA provides distinct clinicopathological features of gastric cancer patients.

Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Yamada H, Yoshida D, Ohmori T, Maeda K, Komura N, Ikuno H, Jodai Y, Kamano T, Nagasaka M, Nakagawa Y, Tsukamoto T, Urano M, Shibata T, Kuroda M, Ohmiya N.

Clin Exp Med. 2018 May;18(2):215-220. doi: 10.1007/s10238-017-0471-4. Epub 2017 Sep 4.

PMID:
28871451
4.

Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.

Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Yamada H, Yoshida D, Ohmori T, Maeda K, Komura N, Ikuno H, Jodai Y, Kamano T, Nagasaka M, Nakagawa Y, Tuskamoto T, Urano M, Shibata T, Kuroda M, Ohmiya N.

Anticancer Res. 2017 Apr;37(4):1997-2001.

PMID:
28373473
5.

Relationship between expression of onco-related miRNAs and the endoscopic appearance of colorectal tumors.

Nakagawa Y, Akao Y, Taniguchi K, Kamatani A, Tahara T, Kamano T, Nakano N, Komura N, Ikuno H, Ohmori T, Jodai Y, Miyata M, Nagasaka M, Shibata T, Ohmiya N, Hirata I.

Int J Mol Sci. 2015 Jan 9;16(1):1526-43. doi: 10.3390/ijms16011526.

6.

Examination of serum pepsinogen in functional dyspepsia.

Tahara T, Shibata T, Okubo M, Yamashita H, Yoshioka D, Yonemura J, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Nakamura M, Arisawa T, Hirata I.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2516-22. doi: 10.5754/hge10604.

PMID:
23178618
7.

[Extraintestinal complications of inflammatory bowel disease].

Nagasaka M, Fujita H, Kamano T, Komura N, Hirata I.

Nihon Rinsho. 2012 Feb;70 Suppl 1:406-10. Japanese. No abstract available.

PMID:
23126127
8.

Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial.

Omori T, Kamiya Y, Tahara T, Shibata T, Nakamura M, Yonemura J, Okubo M, Yoshioka D, Ishizuka T, Maruyama N, Kamano T, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Arisawa T, Hirata I.

BMC Gastroenterol. 2012 Feb 22;12:17. doi: 10.1186/1471-230X-12-17.

9.

Role of heat-shock protein (HSP) 70-2 genotype in peptic ulcer in Japanese population.

Tahara T, Arisawa T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Nakano H, Hirata I.

Hepatogastroenterology. 2012 Mar-Apr;59(114):426-9. doi: 10.5754/hge09606.

PMID:
22353510
10.

Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2).

Nakata B, Tsuji A, Mitachi Y, Taenaka N, Kamano T, Oikawa K, Onoda N, Kambe M, Takahashi M, Shirasaka T, Morita S, Sakamoto J, Tanaka Y, Saji S, Hirakawa K.

Oncology. 2010;79(5-6):337-42. doi: 10.1159/000323286. Epub 2011 Mar 23.

PMID:
21430401
11.

Effect of genetic polymorphisms related to DNA repair and the xenobiotic pathway on the prognosis and survival of gastric cancer patients.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Ishizuka T, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Hirata I, Arisawa T.

Anticancer Res. 2011 Feb;31(2):705-10.

PMID:
21378360
12.

Significance of fecal deoxycholic acid concentration for colorectal tumor enlargement.

Kawano A, Ishikawa H, Kamano T, Kanoh M, Sakamoto K, Nakamura T, Otani T, Sakai T, Kono K.

Asian Pac J Cancer Prev. 2010;11(6):1541-6.

13.

Effect of IL-1β and TNF-α polymorphisms on the prognosis and survival of gastric cancer patients.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T.

Clin Exp Med. 2011 Dec;11(4):211-7. doi: 10.1007/s10238-010-0129-y. Epub 2011 Jan 19.

PMID:
21246243
14.

[Low-dose aspirin induced intestinal damage -including the influence of low-dose aspirin to existing lesions-].

Shibata T, Kamano T, Hirata I.

Nihon Shokakibyo Gakkai Zasshi. 2010 Dec;107(12):1910-5. Review. Japanese. No abstract available.

PMID:
21139359
15.

Gastrointestinal Stromal Tumor of the Stomach with Narrow Stalk-Like Based, Uneven Protruding Appearance Presenting with Severe Acute Anemia despite Small Size.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakagawa Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Arisawa T, Hirata I.

Case Rep Gastroenterol. 2010 Mar 20;4(1):111-117.

16.

Rapid multiple immunocytochemical staining method using microwave irradiation for intraoperative cytology.

Furuhata A, Sueyoshi N, Kurihara H, Sakamoto K, Kamano T, Hino O.

Acta Cytol. 2010 May-Jun;54(3):283-90.

PMID:
20518412
17.

Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T.

Dig Dis Sci. 2010 Dec;55(12):3449-57. doi: 10.1007/s10620-010-1206-5. Epub 2010 Apr 16.

PMID:
20397048
18.

Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T.

Digestion. 2010;82(1):27-36. doi: 10.1159/000252766. Epub 2010 Feb 11.

PMID:
20150736
19.

CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.

Tahara T, Shibata T, Arisawa T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I.

Anticancer Res. 2010 Jan;30(1):239-44.

PMID:
20150642
20.

Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T.

Int J Mol Med. 2010 Mar;25(3):471-7.

PMID:
20127054
21.

779 TC of CCK-1 intron 1 is associated with postprandial syndrome (PDS) in Japanese male subjects.

Tahara T, Arisawa T, Shibata T, Nakamura M, Wang F, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakamura M, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Nakano H, Hirata I.

Hepatogastroenterology. 2009 Jul-Aug;56(93):1245-8.

PMID:
19760980
22.

Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T.

Int J Mol Med. 2009 Oct;24(4):563-9.

PMID:
19724898
23.

The BB genotype of heat-shock protein (HSP) 70-2 gene is associated with gastric pre-malignant condition in H. pylori-infected older patients.

Tahara T, Shibata T, Arisawa T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Yamashita H, Nakano H, Hirata I.

Anticancer Res. 2009 Aug;29(8):3453-8.

24.

Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa.

Tahara T, Shibata T, Arisawa T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I.

Anticancer Res. 2009 Jul;29(7):2857-61.

25.

COMT gene Val158Met polymorphism influences the severity of intestinal metaplasia in H. pylori infected older subjects.

Tahara T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Nakano H, Hirata I, Arisawa T.

Hepatogastroenterology. 2009 Mar-Apr;56(90):411-5.

PMID:
19579610
26.

Effect of polymorphisms in the 3'-untranslated region (3'-UTR) of VEGF gene on gastric pre-malignant condition.

Tahara T, Arisawa T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Nakano H, Hirata I.

Anticancer Res. 2009 Feb;29(2):485-9.

27.

Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis.

Tahara T, Arisawa T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Hirata I.

Eur J Gastroenterol Hepatol. 2009 Jun;21(6):613-9. doi: 10.1097/MEG.0b013e32830e28b2.

PMID:
19307977
28.

Effect of MDR1 gene promoter methylation in patients with ulcerative colitis.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakagawa Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I, Arisawa T.

Int J Mol Med. 2009 Apr;23(4):521-7.

PMID:
19288029
29.

Genetic variant of the p22PHOX component of NADPH oxidase C242T and the incidence of gastric cancer in Japan.

Tahara T, Arisawa T, Shibata T, Nakamura M, Wang F, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakamura M, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Nakano H, Hirata I.

Hepatogastroenterology. 2008 Nov-Dec;55(88):2273-6.

PMID:
19260521
30.

Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I, Arisawa T.

Dig Dis Sci. 2010 Jan;55(1):54-9. doi: 10.1007/s10620-008-0701-4. Epub 2009 Jan 29.

PMID:
19184424
31.

Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC).

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Nakano H, Hirata I, Arisawa T.

Clin Exp Med. 2009 Jun;9(2):125-30. doi: 10.1007/s10238-008-0025-x. Epub 2009 Jan 30.

PMID:
19184329
32.

MTHFR 677T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects.

Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I, Arisawa T.

Dig Dis Sci. 2009 Nov;54(11):2391-8. doi: 10.1007/s10620-008-0624-0. Epub 2008 Dec 12.

PMID:
19082889
33.

Effect of RANTES promoter genotype on the severity of intestinal metaplasia in Helicobacter pylori-infected Japanese subjects.

Tahara T, Arisawa T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Nakano H, Hirata I.

Dig Dis Sci. 2009 Jun;54(6):1247-52. doi: 10.1007/s10620-008-0497-2. Epub 2008 Oct 29.

PMID:
18958622
34.

Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population.

Wang FY, Tahara T, Arisawa T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakamura M, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Nakano H, Hirata I.

Dig Dis Sci. 2008 Nov;53(11):2904-8. doi: 10.1007/s10620-008-0249-3. Epub 2008 Mar 27.

PMID:
18368489
35.

Malignant lymphoma in the ileum diagnosed by double-balloon enteroscopy.

Beppu K, Osada T, Nagahara A, Sakamoto N, Shibuya T, Kawabe M, Terai T, Ohkusa T, Ogihara T, Sato N, Kamano T, Hayashida Y, Watanabe S.

World J Gastroenterol. 2007 Jun 28;13(24):3388-91.

36.

Kinetic analysis of bile acids in the feces of colorectal cancer patients by gas chromatography-mass spectrometry (GC-MS).

Tadano T, Kanoh M, Kondoh H, Matsumoto M, Mimura K, Kanoh Y, Sakamoto K, Kamano T.

Rinsho Byori. 2007 May;55(5):417-27.

PMID:
17593686
37.

Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study.

Nakata B, Sowa M, Tsuji A, Kamano T, Sasaki K, Fukunaga Y, Takahashi M, Tsujitani S, Mikami Y, Mitachi Y, Nishimura S, Araki H, Yamamitsu S, Hirakawa K, Tominaga S, Shirasaka T, Inokuchi K.

J Exp Clin Cancer Res. 2007 Mar;26(1):51-60.

PMID:
17550132
38.

Analysis of the relationship between sex and chromosomal aberrations in colorectal cancer by comparative genomic hybridization.

Unotoro J, Kamiyama H, Ishido Y, Yaginuma Y, Kasamaki S, Sakamoto K, Oota A, Ishibashi Y, Kamano T.

J Int Med Res. 2006 Jul-Aug;34(4):397-405.

PMID:
16989496
39.

Genomic copy-number aberrations related to lymph-node metastasis of colon cancer.

Yaginuma Y, Unotoro J, Kamiyama H, Ishido Y, Kasamaki S, Sakamoto K, Shindo T, Ishibasi Y, Kamano T.

J Int Med Res. 2006 Jul-Aug;34(4):390-6.

PMID:
16989495
40.

Greater development of 1,2-dimethylhydrazine-induced colon cancer in a rat model of type 2 diabetes mellitus.

Terai K, Sakamoto K, Goto M, Matsuda M, Kasamaki S, Shinmura K, Takita N, Kamano T.

J Int Med Res. 2006 Jul-Aug;34(4):385-9.

PMID:
16989494
41.

Methylenetetrahydrofolate reductase C677T is not associated with expression of pyrimidine metabolic enzyme genes in colorectal cancer.

Takeda R, Kamano T, Sakamoto K, Sugano M, Hosoda S, Watanabe T, Maeda T, Kojima Y.

J Int Med Res. 2006 May-Jun;34(3):307-15.

PMID:
16866026
42.

Simultaneous laparoscopic treatment for rectosigmoid and ileal endometriosis.

Sakamoto K, Maeda T, Yamamoto T, Takita N, Suda S, Watanabe T, Sakamoto S, Kamano T, Takeuchi H, Kinoshita K.

J Laparoendosc Adv Surg Tech A. 2006 Jun;16(3):251-5.

PMID:
16796434
43.

Abdominal wound dehiscence in patients receiving long-term steroid treatment.

Kihara A, Kasamaki S, Kamano T, Sakamoto K, Tomiki Y, Ishibiki Y.

J Int Med Res. 2006 Mar-Apr;34(2):223-30.

PMID:
16749419
44.

Clinicopathological features of nonpolypoid colorectal tumors as viewed from the patients' background.

Abe S, Terai T, Sakamoto N, Beppu K, Nagahara A, Kobayashi O, Ohkusa T, Ogihara T, Hirai S, Kamano T, Miwa H, Sato N.

J Gastroenterol. 2006 Apr;41(4):325-31.

PMID:
16741611
45.

Colonic carcinoma resembling submucosal tumor: report of a case and review of the literature.

Nakajima T, Kamano T, Shibasaki K, Watanabe K, Meguro H, Tomiki Y, Kasamaki S, Adachi M, Watanabe Y.

Int J Gastrointest Cancer. 2005;36(3):155-61. Erratum in: Int J Gastrointest Cancer. 2006;37(1):55.

PMID:
16720911
46.

Early colon cancer detected by 18F-FDG PET.

Sakamoto K, Takahashi M, Yaginuma Y, Ishido Y, Matsuoka T, Sakamoto S, Tomiki Y, Kamano T.

Int J Gastrointest Cancer. 2005;36(2):95-8.

PMID:
16648659
47.

Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1.

Tsuruoka Y, Kamano T, Kitajima M, Kawai K, Watabe S, Ochiai T, Sakamoto K, Shirasaka T.

Anticancer Drugs. 2006 Apr;17(4):393-9.

PMID:
16549996
48.

Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry.

Tadano T, Kanoh M, Matsumoto M, Sakamoto K, Kamano T.

Rinsho Byori. 2006 Feb;54(2):103-10.

PMID:
16548228
49.

The relationship between 5-fluorouracil sensitivity and single nucleotide polymorphisms of the orotate phosphoribosyl transferase gene in colorectal cancer.

Kitajima M, Takita N, Hata M, Maeda T, Sakamoto K, Kamano T, Ochiai T.

Oncol Rep. 2006 Jan;15(1):161-5.

PMID:
16328050
50.

[Five cases of locally advanced rectal cancer or local recurrence performed intra-arterial infusion chemotherapy via the internal iliac artery].

Koide Y, Maeda K, Hanai T, Sato H, Masumori K, Aoyama H, Katsuno H, Funabashi M, Kamano T, Agata T, Noro T.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1718-20. Japanese.

PMID:
16315919

Supplemental Content

Loading ...
Support Center